Cargando…
Lymphangioleiomyomatosis: a clinical review
Lymphangioleiomyomatosis (LAM) is a diffuse cystic lung disease. There are two main types of LAM: sporadic, and LAM associated with the tuberous sclerosis complex (TSC), which is caused by mutations in the TSC1 and TSC2 genes. LAM is characterised by cystic lung disease resulting in progressive dysp...
Autores principales: | O'Mahony, Anne M., Lynn, Evelyn, Murphy, David J., Fabre, Aurelie, McCarthy, Cormac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714539/ https://www.ncbi.nlm.nih.gov/pubmed/33304400 http://dx.doi.org/10.1183/20734735.0007-2020 |
Ejemplares similares
-
The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
por: Gaffney, Brian, et al.
Publicado: (2021) -
Vaping-Associated Lung Injury: A Review
por: O’Callaghan, Marissa, et al.
Publicado: (2022) -
What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?
por: McCarthy, Eibhlín, et al.
Publicado: (2011) -
A review of the physiological and psychological health and wellbeing of naval service personnel and the modalities used for monitoring
por: Sargent, Cliodhna, et al.
Publicado: (2017) -
Exosomes: a new perspective in EGFR-mutated lung cancer
por: Jouida, Amina, et al.
Publicado: (2021)